Epigenetic alterations in gastric carcinogenesis

In Seon Choi1, Tsung Teh Wu

  • 1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.

Cell Research
|April 29, 2005
PubMed

Insights

Epigenetic alterations, specifically DNA methylation, are crucial in gastric cancer development by silencing key genes. Understanding these changes offers potential clinical applications for gastric carcinoma.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Gastric cancer arises from genetic alterations, including oncogene overexpression and tumor suppressor loss.
  • Epigenetic alterations, particularly DNA methylation, are critical in silencing genes during gastric carcinogenesis.
  • CpG island methylation is a key epigenetic mechanism studied in gastric carcinoma.

Purpose of the Study:

  • To review the fundamental aspects of DNA methylation and CpG island methylation.
  • To discuss specific epigenetic alterations in critical genes involved in gastric carcinogenesis.
  • To explore the clinical implications of these epigenetic changes in gastric cancer.

Main Methods:

  • Literature review of epigenetic mechanisms in gastric cancer.
  • Analysis of DNA methylation patterns and their role in gene silencing.
  • Examination of specific gene alterations in gastric carcinogenesis.

Main Results:

  • DNA methylation and CpG island methylation are significant factors in gastric carcinogenesis.
  • Epigenetic silencing of critical genes contributes to tumor development.
  • Specific epigenetic alterations correlate with clinical implications in gastric cancer patients.

Conclusions:

  • Epigenetic alterations, especially DNA methylation, are vital in gastric cancer development.
  • Further research into these epigenetic changes can lead to novel diagnostic and therapeutic strategies for gastric carcinoma.
  • Understanding gene silencing through methylation is key to addressing gastric cancer progression.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...